Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 49.54
+1.18 (2.44%)
Apr 1, 2025, 2:45 PM CST
SHA:688363 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 5,371 | 6,075 | 6,359 | 4,947 | 2,632 | Upgrade
|
| Other Revenue | - | 0.6 | 0.41 | 0.55 | 1.05 | Upgrade
|
| Revenue | 5,371 | 6,076 | 6,359 | 4,948 | 2,633 | Upgrade
|
| Revenue Growth (YoY) | -11.61% | -4.45% | 28.53% | 87.93% | 39.63% | Upgrade
|
| Cost of Revenue | - | 1,659 | 1,482 | 1,118 | 510.98 | Upgrade
|
| Gross Profit | 5,371 | 4,417 | 4,877 | 3,829 | 2,122 | Upgrade
|
| Selling, General & Admin | - | 3,331 | 3,439 | 2,736 | 1,256 | Upgrade
|
| Research & Development | - | 446.35 | 388.19 | 284.34 | 141.16 | Upgrade
|
| Other Operating Expenses | 5,161 | 62.01 | 73.25 | 56.95 | 30.45 | Upgrade
|
| Operating Expenses | 5,161 | 3,847 | 3,915 | 3,083 | 1,452 | Upgrade
|
| Operating Income | 210.18 | 570.18 | 961.48 | 746.46 | 670.05 | Upgrade
|
| Interest Expense | - | -10.74 | -14.52 | -11.08 | - | Upgrade
|
| Interest & Investment Income | - | 39.78 | 50.44 | 45.07 | 52.19 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 3.9 | 25.19 | -12.05 | -16.99 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.48 | 1.71 | -3.88 | -2.62 | -0.77 | Upgrade
|
| EBT Excluding Unusual Items | 207.7 | 604.84 | 1,019 | 765.77 | 704.49 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -18.74 | -0.14 | 7.39 | 3.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -3.42 | -0.24 | 0.04 | 0.05 | Upgrade
|
| Asset Writedown | - | -1.87 | -0.53 | -3.91 | -0.34 | Upgrade
|
| Other Unusual Items | - | 120.91 | 118.32 | 120.9 | 51.36 | Upgrade
|
| Pretax Income | 207.7 | 701.72 | 1,136 | 890.2 | 758.9 | Upgrade
|
| Income Tax Expense | 43.38 | 118.98 | 174.73 | 114.64 | 113.89 | Upgrade
|
| Earnings From Continuing Operations | 164.32 | 582.74 | 961.38 | 775.56 | 645.01 | Upgrade
|
| Minority Interest in Earnings | - | 9.81 | 9.54 | 6.78 | 0.83 | Upgrade
|
| Net Income | 164.32 | 592.56 | 970.92 | 782.33 | 645.84 | Upgrade
|
| Net Income to Common | 164.32 | 592.56 | 970.92 | 782.33 | 645.84 | Upgrade
|
| Net Income Growth | -72.27% | -38.97% | 24.10% | 21.14% | 10.29% | Upgrade
|
| Shares Outstanding (Basic) | 483 | 482 | 481 | 480 | 478 | Upgrade
|
| Shares Outstanding (Diluted) | 483 | 482 | 483 | 483 | 478 | Upgrade
|
| Shares Change (YoY) | 0.32% | -0.27% | 0.03% | 0.95% | 9.47% | Upgrade
|
| EPS (Basic) | 0.34 | 1.23 | 2.02 | 1.63 | 1.35 | Upgrade
|
| EPS (Diluted) | 0.34 | 1.23 | 2.01 | 1.62 | 1.35 | Upgrade
|
| EPS Growth | -72.36% | -38.81% | 24.07% | 20.00% | 0.75% | Upgrade
|
| Free Cash Flow | - | -330.68 | -61.22 | 491.85 | -57.65 | Upgrade
|
| Free Cash Flow Per Share | - | -0.69 | -0.13 | 1.02 | -0.12 | Upgrade
|
| Dividend Per Share | - | 0.380 | 0.610 | 0.490 | 0.410 | Upgrade
|
| Dividend Growth | - | -37.70% | 24.49% | 19.51% | 10.81% | Upgrade
|
| Gross Margin | 100.00% | 72.69% | 76.69% | 77.40% | 80.59% | Upgrade
|
| Operating Margin | 3.91% | 9.38% | 15.12% | 15.09% | 25.45% | Upgrade
|
| Profit Margin | 3.06% | 9.75% | 15.27% | 15.81% | 24.53% | Upgrade
|
| Free Cash Flow Margin | - | -5.44% | -0.96% | 9.94% | -2.19% | Upgrade
|
| EBITDA | 411.58 | 771.58 | 1,124 | 866.92 | 740.23 | Upgrade
|
| EBITDA Margin | 7.66% | 12.70% | 17.68% | 17.52% | 28.12% | Upgrade
|
| D&A For EBITDA | 201.4 | 201.4 | 162.69 | 120.46 | 70.19 | Upgrade
|
| EBIT | 210.18 | 570.18 | 961.48 | 746.46 | 670.05 | Upgrade
|
| EBIT Margin | 3.91% | 9.38% | 15.12% | 15.09% | 25.45% | Upgrade
|
| Effective Tax Rate | 20.89% | 16.96% | 15.38% | 12.88% | 15.01% | Upgrade
|
| Revenue as Reported | - | 6,076 | 6,359 | 4,948 | 2,633 | Upgrade
|
| Advertising Expenses | - | 1,790 | 2,051 | 1,583 | 618.8 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.